Cargando…
The Profile of Use of Rituximab in Tertiary Care Hospitals of Central India
BACKGROUND: Rituximab, one of the most commonly used biologics, was once approved by the United States Food and Drug Association (US FDA) for the management of different systemic autoimmune disorders, and it is now used extensively in managing off-label indications. There is a scarcity of data regar...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084999/ https://www.ncbi.nlm.nih.gov/pubmed/37051423 http://dx.doi.org/10.4103/jpbs.jpbs_520_22 |